261 related articles for article (PubMed ID: 23796180)
1. Genome-wide analysis and modeling of DNA methylation susceptibility in 30 breast cancer cell lines by using CpG flanking sequences.
An J; Kim K; Rhee SM; Chae H; Nephew KP; Kim S
J Bioinform Comput Biol; 2013 Jun; 11(3):1341003. PubMed ID: 23796180
[TBL] [Abstract][Full Text] [Related]
2. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis.
Gitan RS; Shi H; Chen CM; Yan PS; Huang TH
Genome Res; 2002 Jan; 12(1):158-64. PubMed ID: 11779841
[TBL] [Abstract][Full Text] [Related]
3. Predicting aberrant CpG island methylation.
Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846
[TBL] [Abstract][Full Text] [Related]
4. Methylation profiling of CpG islands in human breast cancer cells.
Huang TH; Perry MR; Laux DE
Hum Mol Genet; 1999 Mar; 8(3):459-70. PubMed ID: 9949205
[TBL] [Abstract][Full Text] [Related]
5. Predicting DNA methylation susceptibility using CpG flanking sequences.
Kim S; Li M; Paik H; Nephew K; Shi H; Kramer R; Xu D; Huang TH
Pac Symp Biocomput; 2008; ():315-26. PubMed ID: 18229696
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
7. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias.
Nair SS; Coolen MW; Stirzaker C; Song JZ; Statham AL; Strbenac D; Robinson MD; Clark SJ
Epigenetics; 2011 Jan; 6(1):34-44. PubMed ID: 20818161
[TBL] [Abstract][Full Text] [Related]
8. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.
Shen J; Wang S; Zhang YJ; Wu HC; Kibriya MG; Jasmine F; Ahsan H; Wu DP; Siegel AB; Remotti H; Santella RM
Epigenetics; 2013 Jan; 8(1):34-43. PubMed ID: 23208076
[TBL] [Abstract][Full Text] [Related]
9. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.
Rauch T; Wang Z; Zhang X; Zhong X; Wu X; Lau SK; Kernstine KH; Riggs AD; Pfeifer GP
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5527-32. PubMed ID: 17369352
[TBL] [Abstract][Full Text] [Related]
10. Determining the effect of DNA methylation on gene expression in cancer cells.
Lee CJ; Evans J; Kim K; Chae H; Kim S
Methods Mol Biol; 2014; 1101():161-78. PubMed ID: 24233782
[TBL] [Abstract][Full Text] [Related]
11. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
12. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
McCabe MT; Lee EK; Vertino PM
Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013
[TBL] [Abstract][Full Text] [Related]
13. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
16. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer.
Yan PS; Perry MR; Laux DE; Asare AL; Caldwell CW; Huang TH
Clin Cancer Res; 2000 Apr; 6(4):1432-8. PubMed ID: 10778974
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing.
Ruike Y; Imanaka Y; Sato F; Shimizu K; Tsujimoto G
BMC Genomics; 2010 Feb; 11():137. PubMed ID: 20181289
[TBL] [Abstract][Full Text] [Related]
18. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
20. Methylation target array for rapid analysis of CpG island hypermethylation in multiple tissue genomes.
Chen CM; Chen HL; Hsiau TH; Hsiau AH; Shi H; Brock GJ; Wei SH; Caldwell CW; Yan PS; Huang TH
Am J Pathol; 2003 Jul; 163(1):37-45. PubMed ID: 12819009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
